Although the study is limited by its retrospective design and small
sample size, one of its strengths is its sole focus on nonserous
epithelial ovarian cancer, "which is crucial because these histologies
are linked to hormone stimulation and are associated with longer
survival," the authors write. "These are the women who might benefit
most from HT but who are also at highest theoretical risk of recurrence
as a result of exposure to hormones. We found that these women may
instead actually benefit from HT use."
0
comments
:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.